Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Rev Recent Clin Trials ; 10(3): 187-93, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26435288

RESUMO

There were significant recruitment challenges specific to the PLCO Cancer Screening Trial. Large numbers of participants were to be randomized from ten catchment areas nationwide within time and budgetary constraints. The eligible population was elderly and had to meet health and behavioral thresholds. Informed consent was required to participate and be randomized to screening for three cancers at periodic clinic visits or to a usual care arm that included no clinical visits. Consenting required special efforts to fully explain the trial and its potential scientific benefit to future patients with potentially no benefits but possible harms to PLCO participants. Participation would include continued follow-up for at least 13 years after randomization. Strong collaborative investments were required by the NCI and screening centers (SCs) to assure timely recruitment and appropriate racial participation. A trial-wide pilot phase tested recruitment and protocol follow through at SCs and produced a vanguard population of 11,406 participants. NCI announced the trial nationally in advance of the pilot and followed with an even more intense collaborative role with SCs for the main phase to facilitate trial-wide efficient and timely recruitment. Special efforts to enhance recruitment in the main phase included centralized and local monitoring of progress, cross-linking SCs to share experiences in problem solving, centralized training, substantial additional funding dedicated to recruitment and retention, including specialized programs for minority recruitment, obtaining national endorsement by the American Cancer Society, launching satellite recruitment and screening centers, including minority focused satellites, and adding a new SC dedicated to minority recruitment.


Assuntos
Neoplasias Colorretais/diagnóstico , Detecção Precoce de Câncer/métodos , Neoplasias Pulmonares/diagnóstico , Neoplasias Ovarianas/diagnóstico , Neoplasias da Próstata/diagnóstico , Grupos Raciais/estatística & dados numéricos , Neoplasias Colorretais/etnologia , Neoplasias Colorretais/prevenção & controle , Feminino , Humanos , Neoplasias Pulmonares/etnologia , Neoplasias Pulmonares/prevenção & controle , Masculino , Programas de Rastreamento/organização & administração , Grupos Minoritários/estatística & dados numéricos , Estudos Multicêntricos como Assunto , National Cancer Institute (U.S.) , Inovação Organizacional , Neoplasias Ovarianas/etnologia , Neoplasias Ovarianas/prevenção & controle , Seleção de Pacientes , Projetos Piloto , Avaliação de Programas e Projetos de Saúde , Neoplasias da Próstata/etnologia , Neoplasias da Próstata/prevenção & controle , Ensaios Clínicos Controlados Aleatórios como Assunto , Estados Unidos
2.
Rev Recent Clin Trials ; 10(3): 181-6, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26238208

RESUMO

Biomedical research cannot succeed without funding, knowledgeable staff, and appropriate infrastructure. There are however equally important but intangible factors that are rarely considered in planning large multidisciplinary endeavors or evaluating their success. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial required extensive collaborations between individuals from many fields, including clinicians, clinical trialists, and administrators; it also addressed questions across the spectrum of cancer prevention and control. In this manuscript, we examine the experiences and opinions of trial staff regarding the building of successful relationships in PLCO. We summarize, in narrative form, data collected using open-ended questionnaires that were administered to the National Cancer Institute project officers, coordinating center staff, screening center principal investigators, and screening center coordinators in 2015, about 3 years after publication of the final primary trial manuscript. Trust, respect, listening to others, and in-person interaction were frequently mentioned as crucial to building successful relationships.


Assuntos
Neoplasias Colorretais/diagnóstico , Detecção Precoce de Câncer/métodos , Comunicação Interdisciplinar , Neoplasias Pulmonares/diagnóstico , Neoplasias Ovarianas/diagnóstico , Neoplasias da Próstata/diagnóstico , Neoplasias Colorretais/prevenção & controle , Comportamento Cooperativo , Feminino , Humanos , Neoplasias Pulmonares/prevenção & controle , Masculino , National Cancer Institute (U.S.) , Inovação Organizacional , Neoplasias Ovarianas/prevenção & controle , Seleção de Pacientes , Neoplasias da Próstata/prevenção & controle , Controle de Qualidade , Ensaios Clínicos Controlados Aleatórios como Assunto , Inquéritos e Questionários , Estados Unidos
3.
Clin Trials ; 6(1): 52-9, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19254935

RESUMO

BACKGROUND: The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) is a US National Cancer Institute (NCI)-funded randomized controlled trial designed to evaluate whether certain screening tests reduce mortality from prostate, lung, colorectal, and ovarian cancer. To obtain adequate statistical power, it was necessary to enroll over 150,000 healthy volunteers. Recruitment began in 1993 and ended in 2001. PURPOSE: Our goal is to evaluate the success of recruitment methods employed by the 10 PLCO screening centers. We also provide estimates of recruitment yield and cost for our most successful strategy, direct mail. METHODS: Each screening center selected its own methods of recruitment. Methods changed throughout the recruitment period as needed. For this manuscript, representatives from each screening center provided information on methods utilized and their success. RESULTS: In the United States between 1993 and 2001, ten screening centers enrolled 154,934 study participants. Based on participant self-report, an estimated 95% of individuals were recruited by direct mail. Overall, enrollment yield for direct mail was 1.0%. Individual center enrollment yield ranged from 0.7% to 3.8%. Cost per enrolled participant was $9.64-35.38 for direct mail, excluding personnel costs. LIMITATIONS: Numeric data on recruitment processes were not kept consistently at individual screening centers. Numeric data in this manuscript are based on the experiences of 5 of the 10 centers. CONCLUSIONS: Direct mail, using rosters of names and addresses from profit and not-for-profit (including government) organizations, was the most successful and most often used recruitment method. Other recruitment strategies, such as community outreach and use of mass media, can be an important adjunct to direct mail in recruiting minority populations.


Assuntos
Programas de Rastreamento/organização & administração , Neoplasias/prevenção & controle , Seleção de Pacientes , Ensaios Clínicos Controlados Aleatórios como Assunto , Idoso , Neoplasias Colorretais/prevenção & controle , Relações Comunidade-Instituição , Feminino , Humanos , Masculino , Meios de Comunicação de Massa , Programas de Rastreamento/economia , Pessoa de Meia-Idade , Neoplasias/mortalidade , Neoplasias Ovarianas/prevenção & controle , Serviços Postais , Neoplasias da Próstata/prevenção & controle , Estados Unidos
4.
Lung Cancer ; 47(1): 9-15, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15603850

RESUMO

The Lung Screening Study (LSS) was a pilot study designed to assess the feasibility of conducting a large scale randomized controlled trial (RCT) of low radiation dose spiral computed tomography (LDCT) versus chest X-ray (CXR) for lung cancer screening. Baseline results of LSS have been previously reported. Here, we report on the findings at the year one screen and on the final results of the LSS study. A total of 1660 subjects were randomized to the LDCT arm and 1658 to the CXR arm. Compliance with screening declined from 96% at baseline to 86% at year one in the LDCT arm and declined from 93% at baseline to 80% at year one in the CXR arm. Positivity rates for the year one screen were 25.8% for LDCT and 8.7% for CXR. Cancer yield was significantly less at year one for LDCT, 0.57%, than at baseline, 1.9%; cancer yield for CXR increased from 0.45% at baseline to 0.68% at year one. Forty lung cancers in the LDCT arm and 20 in the CXR arm were diagnosed over the study period. Stage I cancers comprised 48% of cases in the LDCT arm and 40% in the CXR arm. A total of 16 stage III-IV cancers were observed in the LDCT arm versus nine in the CXR arm. The LSS has established the feasibility of a RCT comparing annual spiral CT to chest X-ray for lung cancer screening.


Assuntos
Neoplasias Pulmonares/diagnóstico por imagem , Programas de Rastreamento , Radiografia Torácica , Idoso , Estudos de Viabilidade , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Sensibilidade e Especificidade , Tomografia Computadorizada Espiral
5.
J Agromedicine ; 9(2): 291-305, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-19785223

RESUMO

The project goal was to collaborate with veterinarians in delivering skin cancer information to a farming population. Two interventions and a control were utilized: in nine Wisconsin counties veterinarians delivered education materials as part of routine dairy herd health visits, veterinarians in nine additional counties provided client lists so education materials could be mailed, and veterinarians in nine control counties provided client lists but farmers received no education materials. A questionnaire was administered by phone to a random sample of farmers in each group, assessing knowledge, sun protection attitudes and behaviors, acceptance of veterinarians in a human health education role. Farmers responded quite favorably to veterinarians in this role. Veterinarians can be regarded as useful agents to disseminate health information to isolated rural populations.


Assuntos
Agricultura , Educação em Saúde/métodos , População Rural , Médicos Veterinários , Adulto , Doenças dos Trabalhadores Agrícolas/prevenção & controle , Doenças dos Trabalhadores Agrícolas/psicologia , Animais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Roupa de Proteção/estatística & dados numéricos , Neoplasias Cutâneas/prevenção & controle , Neoplasias Cutâneas/psicologia , Luz Solar/efeitos adversos , Protetores Solares/administração & dosagem , Inquéritos e Questionários , Wisconsin
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA